Pharmacokinetic, pharmacodynamic, and pharmacogenetic assays to monitor clopidogrel therapy-Reference-Cited by-同舟云学术

Pharmacokinetic, pharmacodynamic, and pharmacogenetic assays to monitor clopidogrel therapy

Published:2020-11-17 Issue:6 Volume:8 Page:
ISSN:2052-1707
Container-title:Pharmacology Research & Perspectives
language:en
Short-container-title:Pharmacol. Res. Perspect.

Author:

Alvitigala Bhawani Yasassri¹^ORCID,Gooneratne Lallindra Viranjan²,Constantine Godwin Roger³,Wijesinghe Rajapaksha Arachchige Namal Kumaras⁴,Arawwawala Liyanage Dona Ashanthi Menuka⁵

Affiliation:

1. Department of Medical Laboratory Science Faculty of Health Sciences The Open University of Sri Lanka Nugegoda Sri Lanka

2. Department of Pathology Faculty of Medicine University of Colombo Colombo Sri Lanka

3. Department of Clinical Medicine Faculty of Medicine University of Colombo Colombo Sri Lanka

4. Department of Clinical Sciences Faculty of Medicine General Sir John Kotelawala Defense University Ratmalana Sri Lanka

5. Research & Development Complex Industrial Technology Institute Malabe Sri Lanka

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/prp2.686

Reference132 articles.

1. How I use laboratory monitoring of antiplatelet therapy

2. Repetitive stent thrombosis in a patient who had resistance to both clopidogrel and prasugrel

3. Clopidogrel Resistance: Identifying and Overcoming a Barrier to Effective Antiplatelet Treatment

4. Increased Platelet Inhibition After Switching From Maintenance Clopidogrel to Prasugrel in Japanese Patients With Stable Coronary Artery Disease

5. Randomized, Double-Blind, Dose-Finding, Phase II Study of Prasugrel in Japanese Patients Undergoing Elective Percutaneous Coronary Intervention

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population pharmacokinetic‐pharmacodynamic modeling of clopidogrel for dose regimen optimization based on CYP2C19 phenotypes: A proof of concept study;CPT: Pharmacometrics & Systems Pharmacology;2023-10-04

2. Clopidogrel Resistance and Ticagrelor Replacement in Dual Antiplatelet Therapy for Carotid Artery Stenting;Annals of Vascular Surgery;2023-03

3. Resistance on the Latest Oral and Intravenous P2Y12 ADP Receptor Blockers in Patients with Acute Coronary Syndromes: Fact or Myth?;Journal of Clinical Medicine;2022-12-04

4. Genotyping genetic variants of CYP2C19 for precision antiplatelet dosing: state of the art and future perspectives;Expert Opinion on Drug Metabolism & Toxicology;2022-12-02

5. Multi-institutional patterns of clopidogrel response among patients undergoing transcarotid artery revascularization;Vascular;2022-11-25